Organized by Shanghai Center for Interdisciplinary Studies of Chinese Academy of Sciences (CAS) and co-organized by Shanghai Life Sciences Institute of CAS and Shanghai Advanced Research Institute of CAS, the seminar named "Cancer Stem Cell and Cancer Treatment" was held in Shanghai Center for Interdisciplinary Studies from July 6th to 7th, 2010. Vice President of CAS JIANG Mianheng, Director General of Biological Bureau ZHANG Zhibin, Vice President of CAS Shanghai Branch ZHU Zhiyuan, Director and Vice Director of Shanghai Biological Sciences Institute CHEN Xiaoya and LI Lin, Director of SARI FENG Songlin and Vice Directors JIANG Biao, SUN Yuhan and HUANG Weiguang et al. attended the conference.

Over 40 experts and professionals from both home and broad attended the seminar, including those from Washington University, The University of Michigan, Systems Biology Research Institute of America, Anderson Cancer Research Center of America, Shanghai Health Institute, Biochemical and Cell Institute, etc.

Prof LI Lingheng from America's Medical Research Center, Stowe introduced the goals and contents to be discussed in this conference. Prof. CHEN Xiaoya, Prof. FENG Songlin, expressed their positive attitude towards cooperation on behalf of Shanghai Biological Sciences Institute and Shanghai Advanced Research Institute respectively. They both hoped that experts present can put forward their ideas on the measures or medicine that can transfer cutting-edge research results into real practice and make it play a vital role in the national economy in a rapid pace. Their valuable suggestion would contribute to the establishment of stem cells and tumor center bearing Chinese characteristics, the treatment of cancer and development of biological medicine.

Prof. ZHANG Zhibin introduced the recent visit to Systems Biology Research Institute of America by CAS President LU Yongxiang, and made it clear that Biological Bureau will enhance innovation in infrastructure and biology industry under the instructions from President LU and actively engage in cooperation with overseas Chinese scientists. It is expected that Shanghai Advanced Research Institute and Shanghai Biological Sciences Institute would launch the formation of the research center of Stem Cell and Regenerative medicine in the near future, and establish a dedicated major project.

During the seminar, experts exchanged their ideas on the latest technology and hot topics of stem cell and made a comparison between domestic and foreign development. They also carefully evaluated the opportunity and advantage of China and conducted in-depth discussion about the construction of Stem Cell and Regenerative medicine research center in CAS.